GelStat (GSAC) Stock Overview
GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
GSAC Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
GelStat Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0003 |
| 52 Week High | US$0.0005 |
| 52 Week Low | US$0.0002 |
| Beta | 2.97 |
| 1 Month Change | -25.00% |
| 3 Month Change | -14.29% |
| 1 Year Change | 0% |
| 3 Year Change | -66.67% |
| 5 Year Change | -92.31% |
| Change since IPO | -99.95% |
Recent News & Updates
No updates
Recent updates
Shareholder Returns
| GSAC | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -14.3% | 2.7% | 3.1% |
| 1Y | 0% | 25.1% | 14.6% |
Return vs Industry: GSAC underperformed the US Pharmaceuticals industry which returned 25.1% over the past year.
Return vs Market: GSAC underperformed the US Market which returned 14.6% over the past year.
Price Volatility
| GSAC volatility | |
|---|---|
| GSAC Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine GSAC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 2 | Javier Acosta | www.gelstat.com |
GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers.
GelStat Corp. Fundamentals Summary
| GSAC fundamental statistics | |
|---|---|
| Market cap | US$1.12m |
| Earnings (TTM) | -US$283.40k |
| Revenue (TTM) | US$363.53k |
Is GSAC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GSAC income statement (TTM) | |
|---|---|
| Revenue | US$363.53k |
| Cost of Revenue | US$107.56k |
| Gross Profit | US$255.97k |
| Other Expenses | US$539.37k |
| Earnings | -US$283.40k |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.000076 |
| Gross Margin | 70.41% |
| Net Profit Margin | -77.96% |
| Debt/Equity Ratio | -70.7% |
How did GSAC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/25 16:16 |
| End of Day Share Price | 2025/12/22 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
GelStat Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.